|
GD Culture Group, a struggling tech firm with Chinese ties and reliance on TikTok, plans to invest $300 million in Bitcoin and the $TRUMP meme coin, raising ethical concerns due to Trump's involvement and potential conflicts of interest.
Category:
News and Media
GSK is set to acquire efimosfermin, a promising liver disease drug, from Boston Pharmaceuticals for a potential $2 billion. The deal includes an upfront payment of $1.2 billion and milestone payments. Efimosfermin, targeting steatotic liver disease and MASH, is expected to launch in 2029, with GSK also planning to explore its use for alcohol-related liver disease.
Category:
News and Media
Britain's competition watchdog wants to review a 3.7bn deal that would see Aviva takeover Direct Line.
Category:
News and Media
All news |
||||||||||||||||||
|